DK2354148T3 - Nukleosidanaloger og oligonukleotiderivate omfattende nukleotidanalog deraf - Google Patents

Nukleosidanaloger og oligonukleotiderivate omfattende nukleotidanalog deraf

Info

Publication number
DK2354148T3
DK2354148T3 DK10011213.5T DK10011213T DK2354148T3 DK 2354148 T3 DK2354148 T3 DK 2354148T3 DK 10011213 T DK10011213 T DK 10011213T DK 2354148 T3 DK2354148 T3 DK 2354148T3
Authority
DK
Denmark
Prior art keywords
analogs
oligonucleotide derivatives
nucleoside
nucleotide
nucleotide analogs
Prior art date
Application number
DK10011213.5T
Other languages
English (en)
Inventor
Takeshi Imanishi
Original Assignee
Takeshi Imanishi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeshi Imanishi filed Critical Takeshi Imanishi
Application granted granted Critical
Publication of DK2354148T3 publication Critical patent/DK2354148T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK10011213.5T 2002-02-13 2003-02-13 Nukleosidanaloger og oligonukleotiderivate omfattende nukleotidanalog deraf DK2354148T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002035706 2002-02-13
EP03705109A EP1481983A4 (en) 2002-02-13 2003-02-13 NUCLEOSIDE ANALOGUE AND OLIGONUCLEOTIDE DERIVATIVES CONTAINING A NUCLEOTIDE ANALOGON THEREOF

Publications (1)

Publication Number Publication Date
DK2354148T3 true DK2354148T3 (da) 2013-10-14

Family

ID=27678064

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10011213.5T DK2354148T3 (da) 2002-02-13 2003-02-13 Nukleosidanaloger og oligonukleotiderivate omfattende nukleotidanalog deraf

Country Status (7)

Country Link
US (1) US7615619B2 (da)
EP (2) EP2354148B1 (da)
JP (2) JP4383176B2 (da)
AU (1) AU2003211953A1 (da)
DK (1) DK2354148T3 (da)
ES (1) ES2431586T3 (da)
WO (1) WO2003068795A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7427672B2 (en) 2003-08-28 2008-09-23 Takeshi Imanishi Artificial nucleic acids of n-o bond crosslinkage type
WO2007026824A1 (ja) * 2005-08-31 2007-03-08 Osaka University オリゴヌクレオチド類縁体
WO2010150789A1 (ja) 2009-06-23 2010-12-29 武田薬品工業株式会社 核酸の合成法
AU2010312751B2 (en) 2009-10-29 2014-07-24 Osaka University Bridged artificial nucleoside and nucleotide
EP2551273A4 (en) 2010-01-20 2013-10-16 Univ Tokyo PHOSPHORYLATION REAGENT
ES2622716T3 (es) * 2012-09-21 2017-07-07 Osaka University Oligonucleótido y nucleósido artificial en puente con guanidina
WO2014051076A1 (ja) 2012-09-28 2014-04-03 株式会社Ｂｎａ Ｂｎａクランプ法
WO2014112463A1 (ja) * 2013-01-15 2014-07-24 国立大学法人大阪大学 スルホンアミド構造を有するヌクレオシドおよびヌクレオチド
WO2014126229A1 (ja) 2013-02-18 2014-08-21 塩野義製薬株式会社 含窒素複素環構造を有するヌクレオシド及びヌクレオチド
EP3109254B1 (en) 2014-02-18 2018-04-11 Osaka University Crosslinked nucleoside and nucleotide
GB201410693D0 (en) 2014-06-16 2014-07-30 Univ Southampton Splicing modulation
CN107109411B (zh) 2014-10-03 2022-07-01 冷泉港实验室 核基因输出的定向增加
TW201718618A (zh) 2015-09-18 2017-06-01 田邊三菱製藥股份有限公司 架橋型核酸ＧｕＮＡ，其製造方法，及中間體化合物
AU2016334804B2 (en) 2015-10-09 2022-03-31 University Of Southampton Modulation of gene expression and screening for deregulated protein expression
CN109312343B (zh) 2015-12-14 2022-09-27 冷泉港实验室 用于治疗常染色体显性精神发育迟滞5型和Dravet综合征的反义寡聚体
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
CN116064544A (zh) 2016-01-26 2023-05-05 日产化学株式会社 单链寡核苷酸
MX2019009305A (es) 2017-02-06 2019-09-19 Nissan Chemical Corp Oligonucleotido de cadena simple.
EP3603648A4 (en) 2017-03-29 2020-12-30 Shionogi & Co., Ltd COMPLEX OF NUCLEIC ACID MEDICINAL AND MULTI-BRANCHED LIPID
TW201920671A (zh) 2017-07-26 2019-06-01 日商日產化學股份有限公司 單股寡核苷酸
SI3673080T1 (sl) 2017-08-25 2024-03-29 Stoke Therapeutics, Inc. Protismiselni oligomeri za zdravljenje bolezenskih stanj in bolezni
IL272864B2 (en) 2017-08-31 2024-03-01 Mitsubishi Tanabe Pharma Corp A therapeutic agent containing an IL-33 antagonist for the treatment of endometriosis
US12060558B2 (en) 2018-05-04 2024-08-13 Stoke Therapeutics, Inc. Methods and compositions for treatment of cholesteryl ester storage disease
JP7413362B2 (ja) 2019-03-29 2024-01-15 シスメックス株式会社 新規人工核酸、その製造方法及び用途
JPWO2021020412A1 (da) 2019-07-30 2021-02-04
US20230348522A1 (en) * 2019-10-18 2023-11-02 Daiichi Sankyo Company, Limited Method for producing bicyclic phosphoramidite
IL298063A (en) 2020-05-11 2023-01-01 Stoke Therapeutics Inc opa1 antisense oligomers for the treatment of conditions and diseases
JPWO2022065413A1 (da) 2020-09-25 2022-03-31
CN118369437A (zh) 2021-12-10 2024-07-19 日东纺绩株式会社 用于检测核酸的对象碱基序列中的变异的方法、选择性地抑制核酸的扩增的方法、及用于实施这些的试剂盒
JP7421718B2 (ja) 2021-12-10 2024-01-25 日東紡績株式会社 核酸の対象塩基配列中における変異を検出するための方法、核酸の増幅を選択的に阻害する方法、およびこれらを実施するためのキット
CN118382707A (zh) 2021-12-10 2024-07-23 日东纺绩株式会社 双链核酸的融解温度升高化剂及其用途
JPWO2023127857A1 (da) 2021-12-27 2023-07-06

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US6770748B2 (en) * 1997-03-07 2004-08-03 Takeshi Imanishi Bicyclonucleoside and oligonucleotide analogue
US6794499B2 (en) * 1997-09-12 2004-09-21 Exiqon A/S Oligonucleotide analogues
CN1273478C (zh) * 1999-02-12 2006-09-06 三共株式会社 新型核苷及低聚核苷酸类似物
JP4151751B2 (ja) * 1999-07-22 2008-09-17 第一三共株式会社 新規ビシクロヌクレオシド類縁体
WO2002018388A1 (fr) * 2000-08-29 2002-03-07 Takeshi Imanishi Analogues de nucleosides et derives d'oligonucleotides renfermant ces analogues

Also Published As

Publication number Publication date
US7615619B2 (en) 2009-11-10
US20060166908A1 (en) 2006-07-27
EP2354148B1 (en) 2013-09-04
EP1481983A4 (en) 2008-04-02
EP2354148A3 (en) 2011-10-19
JP4383176B2 (ja) 2009-12-16
WO2003068795A1 (fr) 2003-08-21
EP2354148A2 (en) 2011-08-10
JP2009215314A (ja) 2009-09-24
AU2003211953A1 (en) 2003-09-04
EP1481983A1 (en) 2004-12-01
JP5030998B2 (ja) 2012-09-19
JPWO2003068795A1 (ja) 2005-06-02
ES2431586T3 (es) 2013-11-27

Similar Documents

Publication Publication Date Title
DK2354148T3 (da) Nukleosidanaloger og oligonukleotiderivate omfattende nukleotidanalog deraf
CY2016052I1 (el) Τροποποιημενα φθοριομενα αναλογα νουκλεοζιδιων
ATE335755T1 (de) Antivirale nukleosidderivate
DK3587433T3 (da) Modificerede nukleotider
AU2003241621A8 (en) Oligonucleotides having modified nucleoside units
DK3266791T3 (da) Mærkede nukleotider
AU2003237249A1 (en) Oligonucleotides having modified nucleoside units
EP1720556A4 (en) NOVEL NUCLEOSIDE DERIVATIVES OF 2'-C-METHYL
NO20024355D0 (no) Nukleosidforbindelser og anvendelser derav
GB0112617D0 (en) Antiviral nucleoside derivatives
EP1816130A4 (en) NOVEL NUCLEOSIDE OR NUCLEOTIDE DERIVATIVE AND USE THEREOF
DK1578755T3 (da) Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
AU2003301589A8 (en) Purine nucleosides
EP1544294A4 (en) NUCLEOSIDE OR NUCLEOTIDE HAVING A NEW NON-NATURAL BASE AND USE THEREOF
DE60324491D1 (de) Kultivator
AU2003296601A8 (en) Antiviral nucleoside derivatives
AU2003290816A8 (en) Modified nucleosides as antiviral agents
ITMI20020198A1 (it) (per)aloeteri
FR2842104B1 (fr) Genes impliques dans la canitie precoce
AU2003217311A8 (en) Base-labeled nucleosides and nucleotides
EP1613722A4 (en) OLIGONUCLEOTIDES INHIBITORS BASED ON RNA
GB0230037D0 (en) Modified nucleotides
HUE050818T4 (hu) Módosított nukleotidok
PL359949A1 (en) Derivative of nucleoside, modified oligonucleotide and method of obtaining derivative of nucleotide
GB0422879D0 (en) Nucleoside and nucleotide analogues and uses thereof